| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |